Friday, May 3, 2024

12:00 pm Fellows Panel
1:00 pm Lunch and Exhibits
1:30 pm Opening Remarks – Aleksandra Rachitskaya, MD & Katherine Talcott, MD


1:35 pm nAMD Pipeline – Dilsher Dhoot, MD
1:45 pm Gene Therapy for nAMD and GA – Katherine Talcott, MD
1:55 pm OCT biomarkers in intermediate AMD and GA – Justis P. Ehlers, MD
2:05 pm  Sustained release strategies – Rishi P. Singh, MD, FASRS
2:15 pm Clinical Trial Design and FDA Guidelines, Where are We Now and Where are We Going –  Jennifer Lim, MD
2:25 pm Panel—Surgical Cases
Moderator: Katherine Talcott, MD
Panel: All Faculty

2:45 pm Break and Exhibits

3:15 pm DRCR Retina network new protocols – Daniel F. Martin, MD
3:25 pm GLP1-RA and Diabetic Retinopathy – Aleksandra Rachitskaya, MD
3:35 pm Novel treatments for DR and DME – Carl D. Regillo, MD, FASRS
3:45 pm Surgical management of complicated macular holes – Sumit Sharma, MD
3:55 pm Management of IRD – Katherine Talcott, MD
4:05 pm Steroids for Retinal Vascular diseases (when, why, real world) – Sumit Sharma, MD
4:15 pm Retinal Vascular Diseases Panel
Moderator: Aleksandra Rachitskaya, MD
Panel: All Faculty

4:35 pm Break and Exhibits

4:55 pm Update on Pegcetacoplan – Dilsher Dhoot, MD
5:05 pm Update on Avacincaptad Pegol – Arshad M. Khanani, MD, MA, FASRS
5:15 pm How to treat patients with dry AMD – Robert L. Avery, MD
5:25 pm Uveitis update – Phoebe Lin, MD, PhD
5:35 pm AMD panel
Moderator: Daniel F. Martin, MD
Panel: All Faculty
5:55 pm Closing remarks